Age, Biography and Wiki
Matthew Krummel (Matthew Frederick Krummel) was born on 28 May, 1968, is a Pathology professor. Discover Matthew Krummel's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 55 years old?
| Popular As |
Matthew Frederick Krummel |
| Occupation |
N/A |
| Age |
55 years old |
| Zodiac Sign |
Gemini |
| Born |
28 May 1968 |
| Birthday |
28 May |
| Birthplace |
N/A |
| Nationality |
|
We recommend you to check the complete list of Famous People born on 28 May.
He is a member of famous Professor with the age 55 years old group.
Matthew Krummel Height, Weight & Measurements
At 55 years old, Matthew Krummel height not available right now. We will update Matthew Krummel's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Matthew Krummel Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Matthew Krummel worth at the age of 55 years old? Matthew Krummel’s income source is mostly from being a successful Professor. He is from . We have estimated Matthew Krummel's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Professor |
Matthew Krummel Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Matthew F. Krummel (Max Krummel) is a Professor in the Pathology Department at University of California, San Francisco.
He is known for Systems Immunology and studies mechanisms that regulate the immune system.
Krummel holds the Robert E. Smith Endowed Chair in Pathology and is the Chair of the UCSF ImmunoX Initiative.
His lab (krummellab) uses real-time imaging to launch and test hypotheses related to how the immune system processes information and makes decisions.
His recent discoveries include determining features of T cell membrane biology and how the movement of immune cells governs their ability to efficiently survey for antigens.
Additionally, his research has revealed archetypal collections of immune systems in cancer, namely those involving networks of cells built around stimulatory dendritic cells.
Krummel developed a novel industry consortium-funded project (immunoprofiler.org) that unites studies of cancer indications to understand the biology of individual patients and founded a microscopy ‘collaboratory’ at UCSF.
He also founded the ImmunoX initiative, together with other UCSF faculty, which is a radical collaboration platform focused on methods and data sharing as a means to accelerate discovery and cures.
Krummel co-founded Foundery Innovations, a novel biotechnology venture fund and studio that translates early-stage drug concepts through extensive academic-industry collaborations, most recently with the University of California, San Francisco, and the University of Arizona.
He founded Pionyr Immunotherapeutics where he discovered new next-generation immunotherapeutics targeting myeloid cells.
In the lab of James P. Allison at UC Berkeley, Krummel conducted key studies on the function of the protein CTLA-4; together they developed and described the first CTLA-4 inhibitors.
They subsequently collaborated to apply the same inhibitors in tumor models, providing data on the blockade of inhibitory receptors can augment tumor immune responses, the basis for the 2018 Nobel Prize in Medicine and Physiology as well as the first patents for anti-CTLA-4 checkpoint blockade.
Krummel received his Ph.D. at the University of California, Berkeley, and completed his postdoctoral studies at Stanford University.
